Jinsong Ren

In the present work, a novel non-lanthanide dual-modality contrast agent, manganese tungstate (MnWO₄), has been successfully constructed by a facile and versatile hydrothermal route. With the merits of a high atomic number and a well-positioned K-edge energy of tungsten, our well-prepared non-lanthanide nanoprobes provide a higher contrast efficacy than routine iodine-based agents in clinics. Additionally, the presence of Mn in these nanoparticles endow them with excellent T₁-weighted MR imaging capabilities. As an alternative to T₂-weighted MRI and CT dual-modality contrast agents, the nanoprobes can provide a positive contrast signal, which prevents confusion with the dark signals from hemorrhage and blood clots. To the best of our knowledge, this is the first report that a non-lanthanide imaging nanoprobe is applied for CT and T₁-weighted MRI simultaneously. Moreover, comparing with gadolinium-based T₁-weighted MRI and CT dual-modality contrast agents that were associated with nephrogenic systemic fibrosis (NSF), our contrast agents have superior biocompatibility, which is proved by a detailed study of the pharmacokinetics, biodistribution, and in vivo toxicology. Together with excellent dispersibility, high biocompatibility and superior contrast efficacy, these nanoprobes provide detailed and complementary information from dual-modality imaging over traditional single-mode imaging and bring more opportunities to the new generation of non-lanthanide nanoparticulate-based contrast agents.

Artificial hyperthermia is an emerging technique to induce apoptotic cancer cell death. However, achieving effective hyperthermic apoptosis is often difficult, as cells typically acquire resistance to thermal stress. With the aid of sequential irradiation, highly integrated nanoassemblies based on reduced graphene oxide–ZnO nanoparticles–hyaluronic acid (rGo‐ZnO‐HA) can serve as a multi‐synergistic platform for targeted high‐performance apoptotic cancer therapy. The surface engineering of ZnO/graphene hybrid with multifunctional HA biomacromolecules simultaneously confers the system colloidal stability, biocompatibility, and a cancer cell targeting ability. After receptor‐mediated endocytosis, enzyme‐mediated fluorescence activation helps track cellular uptake and provides truly molecular imaging. Furthermore, the reactive oxygen species (ROS) generated by ZnO/rGo under light illumination can effectively sensitize cancer cells to the subsequent NIR laser‐induced apoptotic hyperthermia. In particular, photo modulation of cellular ROS to sensitize cells provides a novel approach to increase the efficacy of hyperthermic apoptosis. These findings suggest that a powerful apoptotic therapeutic platform could be achieved based on the multi‐synergistic platform.

A facile one‐pot synthesis of fluorescent AuNCs by using ovalbumin‐CpG oligodeoxynucleotides (ODNs) conjugates as the templates, which can elicit specific immunological responses, is demonstrated. Through dual‐delivery of protein antigen and CpG ODNs, the as‐prepared AuNCs can act as smart self‐vaccines to assist in generation of high immunostimulatory activity while simultaneously act as an imaging agent. The AuNCs‐based vaccines are not thought to have not been reported so far, making this platform the first example of the usage of AuNCs as effective vaccines. Furthermore, compared with the antigen, the immunostimulatory activity of the as‐prepared AuNCs can not only be retained, but also can be effectively enhanced. These findings suggest the AuNCs‐based vaccines may be utilized as safe and efficient immunostimulatory agents that are able to prevent and/or treat a variety of ailments.

Fluorescent silica nanotubes are attracting increasing interest because of their versatile applicability in a range of diverse fields. By using sol-gel transcription of tetraethylorthosilicate (TEOS) from various soft templates, silica nanotubes can be conveniently prepared. Metal-peptide hybrids with well-defined nanostructures and outstanding functionalities are very interesting candidates to serve as templates. Herein, we demonstrate that glutathione (GSH) can act as a building block for a bioinspired structure with dimensions down to the nanoscale, based on specific interactions between metal ions and the peptide. Congo red is able to selectively stain the nanofibres obtained, and appears apple-green in colour, implying that Congo red is promising to serve as an effective and convenient probe for determining the self-assembly of GSH and copper ions. Furthermore, silica nanotubes are synthesized using the nanofibres as a template in a very simple way. The silica nanotubes can be lit up by biomolecule-templated metal nanoparticles or nanoclusters and emit bright fluorescence. This work will certainly open up new opportunities in fabricating a broad range of nanostructured materials with versatile functionalities.

We demonstrate for the first time that PPy–SiO₂–GTA composites can be used as efficient photothermal agents for killing pathogenic bacteria under NIR irradiation. The cell growth of both gram-positive and gram-negative bacteria targeted by PPy–SiO₂–GTA composites could be inhibited effectively after photothermal treatment.

Multifunctional lanthanide‐doped porous nanoparticles are prepared via a facile one‐step solvothermal route by employing aptamers as the biotemplate. The nanoparticles feature excellent aqueous dispersibility and biospecific properties and could work as effective nanoprobes for targeted imaging and drug delivery. With aptamer being in principle available for any kind of target, this synthetic strategy may open the door to a new generation of nanoprobes for bioapplications such as time‐resolved biodetection, multimode bioimaging/biolabeling, and targeted cancer therapy.

A novel 980 nm laser-driven hydrophobic anticancer drug-delivery platform based on hollow CuS nanoparticles is constructed in this work. The excellent synergistic therapy combining drug treatment and photothermal ablation of cancer cells both in vitro and in vivo is demonstrated, which opens up new opportunities for biological and medical applications.